Market Research Logo

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States. During 2011-2018, the US generic drug market grew at a CAGR of 12% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

The report entitled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” provides a comprehensive insight into the historical and current trends as well as the future prospects of the generic drug market in the United States. This study serves as an exceptional tool to understand the sales trends, volume trends, growth, key segments, competitive structure, regulations, major manufacturer, major distributors, top drugs, manufacturing requirements, opportunities and future prospects of the US generic drug market. This report can serve as an excellent guide for manufacturers, consultants, researchers, marketing strategists and all those who plan to foray into the US generic drug market in any form.

Key Questions Answered in This Report:

Historical, current and future sales trends in the US generic drug market?
Historical, current and future prescription trends in the US generic drug market?
Performance of the US generic drug market compared to the US pharmaceutical market?
Performance of the US generic drug market compared to other major generic drug markets?
Structure of the US generic drug market?
Market Breakup by Therapy Area?
Market Breakup by Drug Delivery?
Market Breakup by Distribution Channel?
Competitive landscape in the US generic drug market?
Top US generic drug manufacturers and their market shares?
Distribution of generic drugs in the US?
Top US generic drug distributors and their market shares?
Most prescribed generic drugs in the US?
Pricing analysis of generic drugs?
Value chain analysis of generic drugs in the US?
Regulations in the US generic drug market?
Manufacturing process of generic drugs?
Machinery and raw material requirements for manufacturing generic drugs?
Key success and risk factors in the US generic drug market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 US Generic Drug Market - Introduction
4.1 What are Generic Drugs?
4.2 Unbranded and Branded Generics
4.3 Authorized Generics
4.4 Commoditized and Specialty Generics
5 Why is the US Generic Drug Market So Lucrative
5.1 Patent Expiry of Blockbuster Drugs
5.2 Significant Price Differential between Generics and Innovator Drugs
5.3 Savings for the Government and Third-Party Payers
5.4 Incentives for Dispensing and Prescribing Generic Drugs
5.5 Reimbursement and Lower Co-payments
5.6 Biosimilars
6 Global Generic Drug Market
6.1 Market Performance
6.1.1 Volume Trends
6.1.2 Value Trends
6.2 Market Breakup by Country
6.3 Market Forecast
6.4 Most Prescribed Generic and Branded Drugs
7 US Generic Drug Market
7.1 US Pharmaceutical Market Performance
7.1.1 Volume Trends
7.1.2 Value Trends
7.1.3 Market Breakup by Type
7.1.4 Market Forecast
7.2 US Generic Drug Market Performance
7.2.1 Volume Trends
7.2.2 Value Trends
7.2.3 Market Breakup by Segment
7.2.4 Market Breakup by Therapy Area
7.2.5 Market Breakup by Drug Delivery
7.2.6 Market Breakup by Distribution Channel
7.2.7 Market Forecast
8 Market Breakup by Segment
8.1 Unbranded Generics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Branded Generics
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Therapy Area
9.1 CNS
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cardiovascular
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Dermatology
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Genitourinary/Hormonal
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Respiratory
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Rheumatology
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Diabetes
9.7.1 Market Trends
9.7.2 Market Forecast
9.8 Oncology
9.8.1 Market Trends
9.8.2 Market Forecast
9.9 Others
9.9.1 Market Trends
9.9.2 Market Forecast
10 Market Breakup by Drug Delivery
10.1 Oral
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Injectables
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Dermal/Topical
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Inhalers
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Distribution Channel
11.1 Retail Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Hospital Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
12 US Generic Drug Market - SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 US Generic Drug Market - Value Chain Analysis
13.1 Research and Development
13.2 Raw Material Procurement
13.3 Manufacturing
13.4 Marketing
13.5 Distribution
14 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain
15 Porter’s Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Rivalry
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 US Generic Drug Market- Competitive Landscape
16.1 US Generic Drug Market - Competitive Structure
16.2 US Generic Drug Market - Breakup of Key Players
16.4 US Generic Drug Market - Most Prescribed Generic Drugs
16.5 US Generic Drug Market - Market Breakup by Distribution
16.6 US Generic Drug Market - Pricing Dynamics
17 Regulations in the US Generic Drug Industry
17.1 Overview of Pharmaceutical Regulations
17.2 Drug Applications
17.3 Patents and Market Exclusivity
17.4 Regulatory Requirements for Generic Drugs
17.5 The Hatch-Waxman Act
17.6 Certifications
17.7 Other Important Considerations
18 US Generic Drug Market: Key Success Factors
19 US Generic Drug Market: Road Blocks
20 Requirements for Setting Up a Generic Drug Manufacturing Plant
20.1 Manufacturing Process
20.2 Raw Material Requirements
20.3 Raw Materials Pictures
20.4 Land and Construction Requirements
20.5 Machinery and Infrastructure Requirements
20.6 Machinery Pictures
20.7 Plant Layout
20.8 Packaging Requirements
20.9 Utility Requirements
20.10 Manpower Requirements
21 US Generic Drug Market - Key Company Profiles
21.1 Teva
21.2 Mylan
21.3 Actavis
21.4 Sandoz
21.5 Sun Pharma
21.6 Par Pharmaceuticals
21.7 Endo Pharmaceuticals
21.8 Lupin Pharmaceuticals
21.9 Dr Reddy’s
21.10 Hospira
List of Figures
Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: US: Patent Expiry Exposure (in Billion US$), 2010-2019
Figure 4: US: Savings from Generic Drugs (in Billion US$), 2007-2018E
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2011-2018
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Standards Units), 2011-2018
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2018
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2018
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 10: Global: Generic Drug Market Forecast: Sales Volume (in Billion Standards Units), 2019-2024
Figure 11: US: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2011-2018
Figure 12: US: Pharmaceutical Market: Sales Value (in Billion US$), 2011-2018
Figure 13: US: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2011 and 2018
Figure 14: US: Pharmaceutical Market: Sales Value Breakup of Branded and Generic Drugs (in %), 2011 and 2018
Figure 15: US: Pharmaceutical Market Forecast: Sales Volume (in Million Prescriptions), 2019-2024
Figure 16: US: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 17: US: Generic Drug Market: Sales Volume (in Million Prescriptions), 2011-2018
Figure 18: US: Generic Drug Market: Sales Value (in Billion US$), 2011-2018
Figure 19: US: Generic Drug Market: Breakup by Segment (in %), 2011-2018
Figure 20: US: Generic Drug Market: Breakup by Therapy Area (in %), 2011-2018
Figure 21: US: Generic Drug Market: Breakup by Drug Delivery (in %), 2011-2018
Figure 22: US: Generic Drug Market: Breakup by Distribution Channel (in %), 2011-2018
Figure 23: US: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2019-2024
Figure 24: US: Generic Drug Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 25: Generic Drug Market: Price Structure (US$/Ton)
Figure 25: US: Generic Drug Market: SWOT Analysis
Figure 26: US: Generic Drug Market: Value Chain Analysis
Figure 27: US: Generic Drug Market: Pricing Mechanism and Profit Margins at the Various Levels of the Supply Chain
Figure 28: US: Generic Drug Market: Porter's Five Forces Analysis
Figure 29: US: Generic Drug Market: Unbranded Generics (in Million Prescriptions), 2011 & 2018
Figure 30: US: Generic Drug Market Forecast: Unbranded Generics (in Million Prescriptions), 2019-2024
Figure 31: US: Generic Drug Market: Branded Generics (in Million Prescriptions), 2011 & 2018
Figure 32: US: Generic Drug Market Forecast: Branded Generics (in Million Prescriptions), 2019-2024
Figure 33: US: Generic Drug Market: CNS (in Million US$), 2011 & 2018
Figure 34: US: Generic Drug Market Forecast: CNS (in Million US$), 2019-2024
Figure 35: US: Generic Drug Market: Cardiovascular (in Million US$), 2011 & 2018
Figure 36: US: Generic Drug Market Forecast: Cardiovascular (in Million US$), 2024
Figure 37: US: Generic Drug Market: Dermatology (in Million US$), 2011 & 2018
Figure 38: US: Generic Drug Market Forecast: Dermatology (in Million US$), 2019-2024
Figure 39: US: Generic Drug Market: Genitourinary/Hormonal (in Million US$), 2011 & 2018
Figure 40: US: Generic Drug Market Forecast: Genitourinary/Hormonal (in Million US$), 2019-2024
Figure 41: US: Generic Drug Market: Respiratory (in Million US$), 2011 & 2018
Figure 42: US: Generic Drug Market Forecast: Respiratory (in Million US$), 2019-2024
Figure 43: US: Generic Drug Market: Rheumatology (in Million US$), 2011 & 2018
Figure 44: US: Generic Drug Market Forecast: Rheumatology (in Million US$), 2019-2024
Figure 45: US: Generic Drug Market: Diabetes (in Million US$), 2011 & 2018
Figure 46: US: Generic Drug Market Forecast: Diabetes (in Million US$), 2019-2024
Figure 47: US: Generic Drug Market: Oncology (in Million US$), 2011 & 2018
Figure 48: US: Generic Drug Market Forecast: Oncology (in Million US$), 2019-2024
Figure 49: US: Generic Drug Market: Others (in Million US$), 2011 & 2018
Figure 50: US: Generic Drug Market Forecast: Others (in Million US$), 2019-2024
Figure 51: US: Generic Drug Market: Orals (in Million US$), 2011 & 2018
Figure 52: US: Generic Drug Market Forecast: Orals (in Million US$), 2019-2024
Figure 53: US: Generic Drug Market: Injectables (in Million US$), 2011 & 2018
Figure 54: US: Generic Drug Market Forecast: Injectables (in Million US$), 2019-2024
Figure 55: US: Generic Drug Market: Dermal/Topical (in Million US$), 2011 & 2018
Figure 56: US: Generic Drug Market Forecast: Dermal/Topical (in Million US$), 2019-2024
Figure 57: US: Generic Drug Market: Inhalers (in Million US$), 2011 & 2018
Figure 58: US: Generic Drug Market Forecast: Inhalers (in Million US$), 2019-2024
Figure 59 US: Generic Drug Market: Retail Pharmacies (in Million US$), 2011 & 2018
Figure 60: US: Generic Drug Market Forecast: Retail Pharmacies (in Million US$), 2019-2024
Figure 61: US: Generic Drug Market: Hospital Pharmacies (in Million US$), 2011 & 2018
Figure 62: US: Generic Drug Market Forecast: Hospital Pharmacies (in Million US$), 2019-2024
Figure 63: US: Generic Drug Market: Sales Breakup of Top Players (in %), 2018
Figure 64: US: Generic Drug Market: Volume Share of Top Players (in %), 2018
Figure 65: US: Generic Drug Market: Volume Share by Distribution (in %), 2018
Figure 66: US: Generic Drug Prices as a Percentage of Branded Drug Prices – Based on Number of Competitors
Figure 67: US: Generic Drug Market: Detailed Process Flow
Figure 68: US: Generic Drug Market: Raw Material Requirements
Figure 69: US: Generic Drug Market: Plant Layout
Figure 70: US: Generic Drug Market: Packaging Requirements
List of Tables
Table 1: US: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: US: Expenses of Generic and Branded Drug Manufacturers (in %)
Table 3: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions)
Table 4: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions)
Table 5: US: Generic Drug Market: Sales Performance of Top Players (in Billion US$), 2018
Table 6: US: Generic Drug Market: Volume Performance of Top Players (in Billion Units), 2018
Table 7: US: Generics Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2018
Table 8: US: Overview of Pharmaceutical Regulations
Table 9: US: Generic Drug Market: Land and Construction Requirements
Table 10: US: Generic Drug Market: Machinery and Infrastructure Requirements
Table 11: US: Generic Drug Market: Utility Requirements
Table 12: US: Generic Drug Market: Manpower Requirements

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook